Can we rely on RE-LY?

N Engl J Med. 2009 Sep 17;361(12):1200-2. doi: 10.1056/NEJMe0906886. Epub 2009 Aug 30.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / administration & dosage*
  • Benzimidazoles / adverse effects
  • Dabigatran
  • Humans
  • Pyridines / administration & dosage*
  • Pyridines / adverse effects
  • Stroke / epidemiology
  • Stroke / prevention & control
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Benzimidazoles
  • Pyridines
  • Warfarin
  • Dabigatran